Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EURO RELAX Study: Deep vs. Standard Neuromuscular Block in Laparoscopic Surgery
2019-003033-42Phase 4Active
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Dec 2019
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of rocuronium and Sugammadex in None (2 arms), sponsored by Health Research Institute Hospital La Fe. Primary endpoint: Intra-operative adverse events. Started Dec 2019; status: active.
02
Drugs
rocuroniumSugammadex
Beyond the preview
Go deeper on 2019-003033-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003033-42.